Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster for Adults 2022-10-22 03:25
Brii Biosciences Presents Promising Clinical Data to Support Ongoing Development of Novel HIV Therapeutic Candidates at IDWeek 2022 2022-10-19 20:00
The Grand Hamdan Award goes to two scientists in Australia 2022-10-19 04:05
GenScript ProBio Enters Strategic Collaboration with Hibiocy Co. Ltd, the affiliate of Rojukiss International Public Company Limited (KISS) - the leading Thai-based Beauty & Health company, for the development and manufacturing of COVITRAP™ and future new products. 2022-10-17 23:56
World Health Summit kicks off with German Chancellor Scholz, numerous Government Officials, WHO Director-General Tedros 2022-10-17 10:24
With New Commitment, Gates Foundation Joins Call to Help End Polio 2022-10-17 01:30
Gilead and the IAS start second year of partnership to honor champions of stigma-free HIV care services in Asia and Latin America 2022-10-13 11:10
Novavax Prototype COVID-19 Vaccine Data Support Homologous and Heterologous Boosting and Suggest Benefit Against Variants 2022-10-12 21:35
Brii Biosciences Announces Top-line Results from Phase 1 Study of BRII-296, A Long-Acting Therapy in Development for Postpartum Depression 2022-09-26 20:00
Gates Foundation Announces $1.27 Billion in Health and Development Commitments to Advance Progress Toward the Global Goals 2022-09-22 06:36
MGC Pharmaceuticals Successfully Developed Herbal-inspired Products for Treatment of Long COVID and COVID-19 2022-09-21 17:13
Menarini and SciClone Sign Exclusive Licensing Agreement to Develop and Commercialize Vaborem® in China to Treat Antimicrobial Resistant Infections 2022-09-20 17:00
Apex Circuit (Thailand) Co., Ltd. Awarded at the Asia Responsible Enterprise Awards 2022 for 'Vaccine 100' under Health Promotion Category 2022-09-15 16:48
GILEAD SCIENCES CELEBRATES TOP RANKING BY HEPATITIS & ASIAN PATIENT GROUPS 2022-09-15 10:00
TikoMed's ILB(R) inhibits cell infection by coronaviruses and modulates reactive cytokine release from microglia in vitro 2022-09-13 16:08
German Chancellor Scholz, WHO Director-General Tedros, international ministers at World Health Summit 2022 2022-09-13 15:50
Aldatu Biosciences Adds Another Outbreak Disease to Pandemic Preparedness Portfolio 2022-09-13 00:33
The Outbreak of COVID-19 Unlocked the Demand for Antimicrobial Technologies 2022-09-08 15:12
TikoMed's drug candidate ILB® inhibited infection of human cells by Dengue, Zika and Yellow Fever viruses in vitro, providing further support for its broad spectrum mechanism of action 2022-09-07 14:32
Brii Biosciences Appoints Taiyin Yang to Board of Directors, Strengthening Product Quality Oversight to Support Company Momentum 2022-09-01 07:30
1 9 10 11 12 13 91